Is Tectonic Therapeutic, Inc. (TECX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.2% / 30% | 37.7% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 0.2% / 33% | 37.7% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 0.5% / 33% | 97.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.2% / 33% | 37.7% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 0.5% / 33% | 97.2% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -37.8% | |
| Return on Assets (ROA) | -25.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$60M |
| Free Cash Flow | -$60M |
| Total Debt | $1M |
| Debt-to-Equity | 0.5 |
| Current Ratio | 26.6 |
| Total Assets | $261M |
Price & Trading
| Last Close | $30.76 |
| 50-Day MA | $25.15 |
| 200-Day MA | $21.10 |
| Avg Volume | 388K |
|
52-Week Range
$13.70
| |
About Tectonic Therapeutic, Inc. (TECX)
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Tectonic Therapeutic, Inc. (TECX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Tectonic Therapeutic, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Tectonic Therapeutic, Inc.'s debt ratio?
Tectonic Therapeutic, Inc.'s debt ratio is 0.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.5%.
What are Tectonic Therapeutic, Inc.'s key financial metrics?
Tectonic Therapeutic, Inc. has a market capitalization of $551M. Return on equity stands at -37.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.